Related Experiment Video
Updated: Jun 12, 2026

11:38
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
Published on: July 3, 2014
The less than whole breast radiotherapy approach
1Southern Zone Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia. Margot_Lehman@health.qld.gov.au
Breast (Edinburgh, Scotland)
|June 1, 2010
Summary
Accelerated partial breast irradiation (APBI) offers a shorter, less burdensome alternative to conventional whole breast irradiation (WBI) after breast conserving surgery. This approach may maintain survival benefits while improving quality of life for breast cancer patients.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Conventional whole breast irradiation (WBI) following breast conserving surgery (BCS) improves survival but is lengthy.
- Longer WBI treatment durations negatively impact patient quality of life.
Purpose of the Study:
- To review the rationale and techniques for partial breast irradiation (PBI).
- To evaluate accelerated partial breast irradiation (APBI) as an alternative to WBI.
- To discuss current results and ongoing trials comparing WBI and APBI.
Main Methods:
- Review of techniques for partial breast irradiation, including interstitial brachytherapy, intracavitary brachytherapy (Mammosite), intraoperative radiotherapy, external beam radiotherapy, and permanent seed implant.
- Discussion of the rationale for reducing radiation volume.
- Analysis of existing data on APBI outcomes.
- Overview of 7 prospective randomized controlled trials comparing WBI and APBI.
Main Results:
- APBI involves delivering higher doses of radiation to a limited tissue volume around the tumor cavity.
- Various techniques exist to achieve APBI, each with specific delivery methods.
- Results to date from APBI studies will be presented.
- Ongoing trials are actively recruiting patients to compare WBI and APBI.
Conclusions:
- APBI represents a potentially less burdensome treatment option for select breast cancer patients.
- Further evidence from ongoing randomized trials is crucial for establishing APBI's role.
- The goal is to maintain oncologic efficacy while improving patient quality of life.
